The Canadian Centre for Applied Research in Cancer Control

A qualitative evaluation of patient engagement in the pan-Canadian Oncology Drug Review process – Part 2: Patient group perspectives

Lead Investigator(s): Kelvin Chan Lead Institution: Sunnybrook Research Institute Co-Investigators: Alexandra Chambers, Helen Mai, Linda Rozmovits ARCC Program Area(s): Health Technology Assessment Funding Term: 2017-2018 Patient input into drug funding reviews by Health Technology Assessment (HTA) agencies is essential to ensuring that patient perspectives inform decision-making about drug reimbursement in (more…)